Trial Profile
A Randomised, Double Blind, Placebo Controlled Study to Examine the Safety, Tolerability, Pharmacodynamics and Pharmacokinetic Profile of Single Inhaled Dry Powder Doses of GSK159802 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Sep 2023
Price :
$35
*
At a glance
- Drugs GSK 159802 (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors GSK
- 12 Nov 2006 New trial record.